Evidence map›Paper›PMID 36754955›Full record

ArticleCell discovery2023

Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose.

Yuemiao Zhang, Meng-Ting Luo, Qingqin Wu, Yun-Xia Wang, Xupu Ma, Guanghong Yan, Si-Hang Zhang, Yanli Chen, Na Wan, Liang Zhang and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuemiao Zhang *Central Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Meng-Ting Luo *Central Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Qingqin WuState Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan, China.
Yun-Xia WangCentral Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Xupu MaState Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan, China.
Guanghong YanSchool of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Si-Hang ZhangCentral Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Yanli ChenState Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan, China.
Na WanState Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan, China.
Liang ZhangCentral Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China.
Dingyun YouSchool of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Jia WeiCentral Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China. weijia19631225@163.com.
Zijie ZhangCentral Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China. zijiezhang@ynu.edu.cn.ORCID http://orcid.org/0000-0002-4900-506X
Tai-Cheng ZhouCentral Laboratory, Liver Disease Research Center and Department of Infectious Disease, The Affiliated Hospital of Yunnan University, Kunming, Yunnan, China. zhoutc@ynshhyy.com.
Precise-CoVaccine study group

Funding

National Natural Science Foundation of China (National Science Foundation of China) 202102AA100051National Natural Science Foundation of China (National Science Foundation of China) 81960116, 82060368Yunnan Provincial Science and Technology Department (Yunnan Department of Science and Technology) 202003AC100010Yunnan Provincial Science and Technology Department (Yunnan Department of Science and Technology) 202102AA100051
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36754955
PMCPMC9907876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.